Top Posts
China cuts borrowing rate more than expected to...
Yellen says G7 to give Ukraine funds it...
‘Retail apocalypse’: Wall Street shaken by inflation-induced earnings...
IMF’s Georgieva says finance leaders must prepare for...
House Passes Domestic Terrorism Bill to Use the...
Dallas Man Arrested For Opening Fire in Koreatown...
Here We Go Again: Biden Administration Buys Millions...
Biden Gas Crisis Spiraling: California tops $6 as...
New Study Finds mRNA Vaccines Actually Hurt Long-Term...
AT LEAST 135 Teachers, Aides Have Been Arrested...
  • About Us
  • Contacts
  • Terms and Conditions
  • Privacy Policy
  • Email Whitelisting
  • Investing
  • Stock
  • World News
  • Politics
  • Editor’s Pick
The Market Holders
Politics

Patients Treated with Pfizer’s Paxlovid Experience Second Round of Covid-19 Shortly After Recovering – Doctors are Baffled

by April 29, 2022
April 29, 2022

There are more and more reports of patients who were treated with Pfizer’s antiviral pill experiencing a second round of Covid-19 shortly after recovering, according to NBC.

Pfizer’s Paxlovid became the first US authorized home COVID-19 treatment. The U.S. Food and Drug Administration issued an emergency use authorization for Pfizer’s antiviral pill for the treatment of mild-to-moderate COVID-19 infections in December.

According to the press release, Paxlovid significantly reduced the proportion of people with COVID-19-related hospitalization or death from any cause by 88%.

Biden administration announced this week to double the number of locations that carry Paxlovid.  They secured funding to purchase 20 million treatment courses of the antiviral pill, per CNN.

White House Covid-19 Response Coordinator Dr. Ashish Jha tweeted about Biden’s plan to make the pill available.

“Paxlovid is extraordinarily effective at preventing bad outcomes We’re getting it out to the American people,” he said.

A lot more places where Pax will be available including more test-to-treat

Education for providers to use it more regularly for eligible patients

And more

Paxlovid is extraordinarily effective at preventing bad outcomes

We’re getting it out to the American people

— Ashish K. Jha, MD, MPH (@AshishKJha46) April 22, 2022

But now cases of Covid-19 recurring among people who completed their Paxlovid treatment are being reported. Experts are still investigating the causes and they are baffled.

NBC reported:

Pfizer’s antiviral pills are highly effective at keeping people with Covid out of the hospital, but there are growing reports that, in rare cases, patients treated for the coronavirus with Paxlovid can experience a second round of the disease shortly after recovering.

Infectious disease experts stress that cases of apparent viral rebound, when someone gets better and then soon gets sick again, following Covid treatment are not cause for alarm. However, there are increasing calls for federal agencies to provide greater clarity and guidance about how patients and health care providers should respond.

With mostly just anecdotal reports coming out, questions remain as to whether people whose Covid symptoms return shortly after they take Paxlovid are contagious and should keep isolating to avoid passing the virus to others.

For those who do experience a second round of symptoms, the sudden shift can also leave them anxious about whether they should seek further treatment.

Michael Henry, 31, a vaccinated and boosted software engineer in Philadelphia, first got sick with Covid on April 4, suffering from chills and a fever.

Henry, who has medical conditions that raise his risk of severe disease, got a Paxlovid prescription from an urgent care center the next day. Within 48 hours, he was feeling “totally fine.” But then, one week after his last dose, he got sick once again, with milder cold-like symptoms, and remained sick for about five days.

On Tuesday, Dr. Michael Charness, chief of staff at the VA Boston Healthcare System, posted a pre-print detailing the case of a fully vaccinated and boosted 71-year-old man who recently saw his virus rebound after he took Paxlovid. The case study is under review by a medical journal.

Charness’ patient, who has intermittent asthma, started Paxlovid the day his Covid symptoms began. Two days later, he began a symptom-free week — only to get sick once again for about four days.

Scientific documentation about post-Paxlovid relapse has actually been available since last fall. Pfizer’s application to the FDA for emergency use authorization of Paxlovid stated that in the placebo-controlled clinical trial — which included 2,246 participants — “several subjects appeared to have a rebound in SARS-CoV-2 RNA levels around Day 10 or Day 14” after beginning treatment.

Read the rest of the story here.

The post Patients Treated with Pfizer’s Paxlovid Experience Second Round of Covid-19 Shortly After Recovering – Doctors are Baffled appeared first on The Gateway Pundit.

previous post
Marine Veteran and Business Owner To Challenge “SQUAD” Member Rashida Tlaib in Michigan
next post
The University of Pennsylvania’s China Connections and the Alleged Attempted Assassination of Chinese Whistleblower Dr. Li-Meng Yan

Related Posts

House Passes Domestic Terrorism Bill to Use the...

May 20, 2022

Dallas Man Arrested For Opening Fire in Koreatown...

May 20, 2022

Here We Go Again: Biden Administration Buys Millions...

May 20, 2022

Biden Gas Crisis Spiraling: California tops $6 as...

May 20, 2022

New Study Finds mRNA Vaccines Actually Hurt Long-Term...

May 20, 2022

AT LEAST 135 Teachers, Aides Have Been Arrested...

May 20, 2022

Biden’s Interior Secretary Completely Clueless When Confronted with...

May 20, 2022

Knife-Wielding Man Who Attacked Dave Chappelle Charged with...

May 19, 2022

Michigan Secretary of State Jocelyn Benson Claims Someone...

May 19, 2022

WOW! Biden Regime Hires Michael Chertoff to Lead...

May 19, 2022
Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

  • China cuts borrowing rate more than expected to revive housing sector

    May 20, 2022
  • Yellen says G7 to give Ukraine funds it needs ‘to get through this’

    May 20, 2022
  • ‘Retail apocalypse’: Wall Street shaken by inflation-induced earnings hits

    May 20, 2022
  • IMF’s Georgieva says finance leaders must prepare for more inflation shocks

    May 20, 2022
  • House Passes Domestic Terrorism Bill to Use the FBI to Silence Conservatives Who Disagree With Them (VIDEO)

    May 20, 2022
  • About Us
  • Contacts
  • Terms and Conditions
  • Privacy Policy
  • Email Whitelisting

Copyright © 2022 TheMarketHolders.com All Rights Reserved.

The Market Holders
  • Investing
  • Stock
  • World News
  • Politics
  • Editor’s Pick

Read alsox

STRUCK DOWN: California Law Requiring Racial And LGBT...

April 2, 2022

Just In: Health Officials Confirm First U.S. Case...

May 18, 2022

Proposed Maryland Law Could Allow Babies to be...

March 12, 2022